Literature DB >> 29714151

Vitamin D's Molecular Action Mechanism in Attention-Deficit/ Hyperactivity Disorder: A Review of Evidence.

Ahmad Saedisomeolia1,2,3, Mahsa Samadi1, Fatemeh Gholami1, Marzieh Seyedi1, Mohammad Effatpanah4, Rezvan Hashemi5, Mina Abdolahi1,6, Niyaz Mohammadzadeh Honarvar1.   

Abstract

BACKGROUND &
OBJECTIVE: Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous disorder characterized by hyperactivity, impulsivity and inattention. Children with ADHD have challenges with learning, behavior and psychosocial adjustments, sometimes retained into adulthood. The exact etiology of ADHD is unknown, and the pathophysiology of this disease is complex. Several hypotheses have been raised regarding ADHD pathogenesis, including serotonergic and catecholaminergic signalling pathway dysfunction, neurotropic-related factors, oxidative stress, or neuroinflammation. Vitamin D has an important protective effect against inflammation, oxidative stress and certain neurotrophic factors and neurotransmitter, as well as facilitating dopaminergic and serotonergic functions. Vitamin D levels in children with ADHD are lower than in healthy children, and thus may be involved in the pathogenesis of ADHD. These observations, therefore, confirm the neuroprotective role of vitamin D through multiple molecular mechanisms and can be considered as a promising target in understanding ADHD pathology.
CONCLUSION: In this context, the present study reviews the molecular pathways of vitamin D in ADHD patients. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Attention-deficit/hyperactivity disorder; inflammation; neurotransmitters; neurotrophic factors; oxidative stress; vitamin D.

Mesh:

Substances:

Year:  2018        PMID: 29714151     DOI: 10.2174/1871527317666180501111627

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  4 in total

1.  Attention-deficit/hyperactivity disorder: is there a connection with the immune system?

Authors:  Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-05       Impact factor: 4.785

2.  In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study.

Authors:  Masamichi Yokokura; Kiyokazu Takebasashi; Akiyo Takao; Kyoko Nakaizumi; Etsuji Yoshikawa; Masami Futatsubashi; Katsuaki Suzuki; Kazuhiko Nakamura; Hidenori Yamasue; Yasuomi Ouchi
Journal:  Mol Psychiatry       Date:  2020-05-21       Impact factor: 15.992

3.  A mendelian randomization study on causal effects of 25(OH)vitamin D levels on attention deficit/hyperactivity disorder.

Authors:  Lars Libuda; Roaa Naaresh; Christine Ludwig; Björn-Hergen Laabs; Jochen Antel; Manuel Föcker; Johannes Hebebrand; Anke Hinney; Triinu Peters
Journal:  Eur J Nutr       Date:  2020-11-27       Impact factor: 5.614

Review 4.  Non-pharmacologic management of attention-deficit/hyperactivity disorder in children and adolescents: a review.

Authors:  Mahesh Shrestha; Julianna Lautenschleger; Neelkamal Soares
Journal:  Transl Pediatr       Date:  2020-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.